Zydus Lifesciences Ltd. with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers ...

Zydus will initially pay €256.8 million to acquire 85.6 per cent of Amplitude Surgical's outstanding shares and voting rights at a price of €6.25 per share. The company will later launch a ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

stated “The Amplitude Surgical team and I are delighted to join Zydus. This acquisition by a worldwide healthcare leader is a testament to the successful development of the Company over the last ...

Zydus Lifesciences has secured USFDA approval to market its generic Ketoconazole Shampoo for treating dandruff and fungal ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Following the mandatory cash tender offer, and potential full acquisition of the company, Amplitude would be delisted from the Euronext Paris stock exchange. Zydus’s offer price of €6.25 per ...

With this latest approval, Zydus now holds 418 approvals from the USFDA. The company has filed 483 Abbreviated New Drug Applications (ANDAs), since it began the filing process in fiscal year 2003 ...

Zydus intends to proceed with a compulsory acquisition of the remaining shares from the minority shareholders (squeeze-out) and to delist the Company. Amplitude Surgical is a European MedTech ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...